ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01421212
Recruitment Status : Completed
First Posted : August 22, 2011
Last Update Posted : August 22, 2011
Sponsor:
Information provided by (Responsible Party):
Biotest Pharmaceuticals Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2002
  Actual Study Completion Date : February 2002